Targeting EGFR Activation to Overcome Gemcitabine Resistance in Cholangiocarcinoma
EGFR is a potential target molecule for reducing Gem resistance and enhancing its anti-tumor effects in patients with CCA.
Authors
- Sopit Wongkham (ORCID: https://orcid.org/0000-0001-9578-3041)
- Charupong Saengboonmee (ORCID: https://orcid.org/0000-0003-1476-1129)
- Wunchana Seubwai (ORCID: https://orcid.org/0000-0002-9265-5113)
- Worachart Lert-itthiporn (ORCID: https://orcid.org/0000-0002-7223-0169)
- Raksawan Deenonpoe (ORCID: https://orcid.org/0000-0002-8387-6061)
- Sonexai Kidoikhammouan
- Sumalee Obchoei (ORCID: https://orcid.org/0000-0002-3001-0563)
Institutions
- Prince of Songkla University (TH)
- Khon Kaen University (TH)
Publication Details
- Journal
- Anticancer Research
- Published
- 2024-12-01
- DOI
- https://doi.org/10.21873/anticanres.17366
- Primary Topic
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00